| Don Benson, MD | |
|
460 W 10th Ave Fl 5, Columbus, OH 43210-1240 | |
| (614) 293-3196 | |
| (614) 293-6176 |
| Full Name | Don Benson |
|---|---|
| Gender | Male |
| Speciality | Hematopoietic Cell Transplantation And Cellular Therapy |
| Experience | 25 Years |
| Location | 460 W 10th Ave Fl 5, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003862236 | NPI | - | NPPES |
| 0248753 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | 35083204 (Ohio) | Secondary |
| 207RH0000X | Internal Medicine - Hematology | 35083204 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohio State University State Health System | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Internal Medicine Llc | 5496651408 | 984 |
News Archive
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services draft coverage decision on brain amyloid imaging, particularly given the clear, scientific consensus recommendations provided to CMS by the Association and the Society for Nuclear Medicine and Molecular Imaging regarding appropriate, limited coverage, only in specific populations.
WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond, VA-based Alliance Engineering, Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States.
Taking a page from Chinese herbal medicine, Scottsdale Healthcare and the Translational Genomics Research Institute today initiated the first-in-human clinical trial for pancreatic cancer patients using a compound derived from a plant known as "Thunder God vine."
Humans living in densely populated urban areas have a profound impact not only on their physical environment, but also on the health and fitness of native wildlife. For the first time, scientists have found a direct link between the degree of urbanization and the prevalence and severity of two distinct parasites in wild house finches.
Bristol-Myers Squibb Company today announced interim results from a Phase IIb clinical trial (COMMAND-1) of 395 treatment-naïve, genotype 1 and 4 hepatitis C infected patients in which two doses of the investigational NS5A replication complex inhibitor daclatasvir (BMS-790052), in combination with peginterferon alfa and ribavirin (alfa/RBV), achieved higher virologic response rates through Week 12 than the alfa/RBV control group, with comparable rates of adverse events.
› Verified 3 days ago
| Entity Name | Osu Internal Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740231448 PECOS PAC ID: 5496651408 Enrollment ID: O20031210000658 |
News Archive
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services draft coverage decision on brain amyloid imaging, particularly given the clear, scientific consensus recommendations provided to CMS by the Association and the Society for Nuclear Medicine and Molecular Imaging regarding appropriate, limited coverage, only in specific populations.
WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond, VA-based Alliance Engineering, Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States.
Taking a page from Chinese herbal medicine, Scottsdale Healthcare and the Translational Genomics Research Institute today initiated the first-in-human clinical trial for pancreatic cancer patients using a compound derived from a plant known as "Thunder God vine."
Humans living in densely populated urban areas have a profound impact not only on their physical environment, but also on the health and fitness of native wildlife. For the first time, scientists have found a direct link between the degree of urbanization and the prevalence and severity of two distinct parasites in wild house finches.
Bristol-Myers Squibb Company today announced interim results from a Phase IIb clinical trial (COMMAND-1) of 395 treatment-naïve, genotype 1 and 4 hepatitis C infected patients in which two doses of the investigational NS5A replication complex inhibitor daclatasvir (BMS-790052), in combination with peginterferon alfa and ribavirin (alfa/RBV), achieved higher virologic response rates through Week 12 than the alfa/RBV control group, with comparable rates of adverse events.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Don Benson, MD 700 Ackerman Rd Ste 2120, Columbus, OH 43202-1559 Ph: (614) 293-2594 | Don Benson, MD 460 W 10th Ave Fl 5, Columbus, OH 43210-1240 Ph: (614) 293-3196 |
News Archive
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services draft coverage decision on brain amyloid imaging, particularly given the clear, scientific consensus recommendations provided to CMS by the Association and the Society for Nuclear Medicine and Molecular Imaging regarding appropriate, limited coverage, only in specific populations.
WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond, VA-based Alliance Engineering, Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States.
Taking a page from Chinese herbal medicine, Scottsdale Healthcare and the Translational Genomics Research Institute today initiated the first-in-human clinical trial for pancreatic cancer patients using a compound derived from a plant known as "Thunder God vine."
Humans living in densely populated urban areas have a profound impact not only on their physical environment, but also on the health and fitness of native wildlife. For the first time, scientists have found a direct link between the degree of urbanization and the prevalence and severity of two distinct parasites in wild house finches.
Bristol-Myers Squibb Company today announced interim results from a Phase IIb clinical trial (COMMAND-1) of 395 treatment-naïve, genotype 1 and 4 hepatitis C infected patients in which two doses of the investigational NS5A replication complex inhibitor daclatasvir (BMS-790052), in combination with peginterferon alfa and ribavirin (alfa/RBV), achieved higher virologic response rates through Week 12 than the alfa/RBV control group, with comparable rates of adverse events.
› Verified 3 days ago
Sethu M. Madhavan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3387 Fax: 614-366-0073 | |
Amrik Singh Khalsa, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-2000 Fax: 614-722-4966 | |
Samuel Y. Han, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-6255 Fax: 614-293-1456 | |
Dr. Ruchi Bhatia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Olentangy River Rd, Columbus, OH 43202 Phone: 614-754-5500 Fax: 614-457-9519 | |
Adam T. Ramey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-7499 Fax: 614-366-2360 | |
Albert J. Cook, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-2957 Fax: 614-685-6533 | |
Walter G. Hanel Iv, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3196 Fax: 614-293-4812 |